Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT - Cutler, Corey; Logan, Brent; Nakamura, Ryotaro; Johnston, Laura; Choi, Sung; Porter, David; Hogan, William J.; Pasquini, Marcelo; MacMillan, Margaret L.; Hsu, Jack W.; Waller, Edmund K.; Grupp, Stephan; et al. (Blood, 2014)
Keywords: Adolescent; Adult; Allografts; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease - mortality; Graft vs Host Disease - prevention & control; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents - administration & dosage; Male; Methotrexate - administration & dosage; Middle Aged; Sirolimus - administration & dosage; Stomatitis - mortality; Stomatitis - prevention & control; Survival Rate; Tacrolimus - administration & dosage; Time Factors; Transplantation